Patent · US Active

2 amino-3,4-dihydrcquinazoline derivatives and the use thereof as cathepsin D inhibitors

US9663475B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Markus Klein · Weiterstadt, DE
Christos Tsaklakidis · Weinheim, DE

Key dates

Filing date	Jan 20, 2014
Grant date	May 30, 2017
Priority date	—
Expiry date	Jan 20, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.